These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2647032)

  • 1. Plasma aldosterone and renin activity.
    Scammell AM; Diver MJ
    Arch Dis Child; 1989 Jan; 64(1):139-41. PubMed ID: 2647032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
    Qin S; Ma C
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Feb; 19(1):29-31. PubMed ID: 2060462
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
    Dzau VJ; Swartz SL
    Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
    Radzevich AE; Ditiatkov AE; Tikhonov VA
    Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
    Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K
    Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy].
    Popovich MI; Zatushevskiĭ IF; Botnar' VI
    Ter Arkh; 1986; 58(11):65-7. PubMed ID: 3547749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin system in congestive cardiac failure: a selective review.
    Brown JJ; Fraser R; Lever AF; Robertson JI
    Eur Heart J; 1983 Jan; 4 Suppl A():85-7. PubMed ID: 6341066
    [No Abstract]   [Full Text] [Related]  

  • 11. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
    Jungmann E; Störger H; Althoff PH; Hadler D; Fassbinder W; Bussmann WD; Kaltenbach M; Schöffling K
    Eur J Clin Pharmacol; 1985; 28(1):1-4. PubMed ID: 3886398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure.
    Covit AB; Schaer GL; Sealey JE; Laragh JH; Cody RJ
    Am J Med; 1983 Sep; 75(3):445-7. PubMed ID: 6351608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 4. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease and cardiovascular insufficiency].
    Korkusko OV; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN
    Z Alternsforsch; 1989; 44(3):149-54. PubMed ID: 2669367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
    Bayliss J; Norell M; Canepa-Anson R; Sutton G; Poole-Wilson P
    Br Heart J; 1987 Jan; 57(1):17-22. PubMed ID: 3541995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of captopril on congestive heart failure.
    Nishida M; Matsuo H; Sano H; Obata H; Yasuda H
    Jpn Circ J; 1990 Dec; 54(12):1497-502. PubMed ID: 2077146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 3. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease without cardiovascular failure].
    Korkusko V; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN
    Z Alternsforsch; 1989; 44(3):141-8. PubMed ID: 2669366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of captopril on renin-aldosterone system in essential hypertension].
    Yu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):84-5. PubMed ID: 3058446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.